India's Glenmark Reports Molecule Key To Blood, Lymph Cancers
This article was originally published in PharmAsia News
Executive Summary
India's Glenmark Pharmaceuticals said it has discovered that a drug molecule that can treat inflammatory problems also is effective against blood and lymph cancers